triolein and Adenocarcinoma

triolein has been researched along with Adenocarcinoma* in 1 studies

Other Studies

1 other study(ies) available for triolein and Adenocarcinoma

ArticleYear
Heparin-modulated binding of pancreatic lipase and uptake of hydrolyzed triglycerides in the intestine.
    The Journal of biological chemistry, 1989, Dec-05, Volume: 264, Issue:34

    Utilizing small intestine membranes that contain heparin (50 micrograms/mg protein), binding of triglyceride lipase (homogeneous 52 kDa, specific activity, 70 nmol/mg.h) to membranes was shown to be concentration dependent and saturable, and it was characterized by a single dissociation constant (KD = 86 +/- 16 nM) with a maximal binding capacity of 54 +/- 8 pmol/mg of vesicle protein. Specific binding was decreased in a concentration-dependent manner by the addition of exogenous heparin, and binding was virtually eliminated (less than 6% control values) by pretreatment of membranes with bacterial heparinase. Cultured intestinal epithelial cells (CaCo-2), shown to possess membrane-associated heparin, also bound pancreatic triglyceride lipase in a specific and saturable manner, with KD = 77 +/- 12 nM and Bmax = 13.7 +/- 6 pmol/10(6) cells. Soluble heparin not only decreased binding, but it also diminished the enzyme-mediated cellular uptake of [14C]oleate from [14C]triolein by over 75%. Therefore, intestinal heparin, a component of the brush border membrane, localizes pancreatic triglyceride lipase in a receptor-like manner to the plasma membrane to promote the subsequent absorption of fatty acids derived from hydrolyzed triglycerides.

    Topics: Adenocarcinoma; Animals; Biological Transport; Cell Line; Colonic Neoplasms; Heparin; Humans; Hydrolysis; Intestine, Small; Kinetics; Lipase; Microvilli; Muscle, Smooth; Oleic Acid; Oleic Acids; Pancreas; Protein Binding; Rabbits; Triolein; Tumor Cells, Cultured

1989